Why GeneDx Holdings Stock Just Dropped 16.6%
GeneDx met Wall Street's revenue target but missed on test volume and trimmed its volume growth outlook, and a stock priced on growth is paying for it.
·
The Motley Fool
Anthropic IPO: Here’s What Betting Markets Are Predicting After the AI Correction
With AI stocks slumping, the Anthropic IPO.
·
The Motley Fool
Split $3,000 Across These 3 Value Stocks and Ignore Them Until 2031
If you can look past all the noise and volatility, there are long-term bargains worth stepping into here.
·
The Motley Fool
Prediction: This Underrated Semiconductor Stock Will Jump 187% in 3 Years
The growth in Qualcomm's non-handset business could supercharge the stock's performance following poor returns in 2026.
·
The Motley Fool
Will Jensen Huang Still Run Nvidia at the End of 2027? Two Analysts Disagree
Two Motley Fool analysts take sides on this hot topic.
·
The Motley Fool
If a Stock Market Crash Is Coming, This Is What Warren Buffett Says Investors Should Do
A downturn in the markets could be a great time for investors to lock in some deals, because they might not last for long.
·
The Motley Fool
